USA healthtech

  The global immune thrombocytopenia market is likely to derive growth from recent advancements in treatment methods of the disease. According to a report published by Fortune Business Insights, titled “  Immune Thrombocytopenia Market Size, Share & Industry Analysis, By Type (Acute Immune Thrombocytopenia, and Chronic Immune thrombocytopenia), By Treatment (Thrombopoietin Receptor Agonist, Immunoglobulins, Corticosteroids, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Others) and Regional Forecast, 2019-2026 ,” the market was valued at USD 2.99 Billion in 2018, and is projected to reach USD 3.33 Billion by 2026, exhibiting a CAGR of 0.54% during the forecast period. Request a Sample Copy of the Global Immune Thrombocytopenia Market Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/immune-thrombocytopenia-itp-market-101682 Some of the leading companies that are operating in the market are: Amgen Inc. Novartis AG Rige

  The global infusion pump market size is predicted to reach USD 16.09 billion by 2026, exhibiting a CAGR of 7.1% during the forecast period. The increasing prevalence of chronic diseases will spur demand for infusion pumps in the forthcoming years. Moreover, the growing advancements in drug delivery systems will boost the infusion pumps market trends during the forecast period. The increasing adoption of advanced treatment techniques will have a positive impact on the infusion pump market growth in the foreseeable future. Request a Sample Copy of the Research Report:  https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/infusion-pump-market-102554 Key Players Operating in The Infusion Pump Market Include: Medtronic BD Baxter Insulet Corporation icumedical Braun Melsungen AG Smiths Medical (Smiths Group plc.) Fresenius Kabi AG Terumo Corporation As per the published report by Fortune Business Insights, titled “Infusion Pump Market Size, Share & Industry Analysis, By T

  Digital PCR Market Size | 2022 Covid-19 Impact On Healthcare Industry Global Analysis By Size, Trends, Growth, Share, Business, Key Players And Regional Forecast latest study published by Fortune Business Insights. The global “Digital PCR Market” is forecast to reach USD 799.1 million by 2026, attributed to the increasing prevalence of infectious diseases and genetic disorders worldwide. Digital PCR is the biotechnological advancement of conventional PCR and provides a reproducible and sensitive method of measuring the amount of RNA or DNA in a sample. Fortune Business Insights discusses the market and its growth trajectories in a recently published report titled, “Digital PCR Market Size, Share & Industry Analysis, By Type (Droplet Digital PCR, Chip-based Digital PCR, and Others), By Product (Instruments and Reagents & Consumables), By Indication (Infectious Diseases, Oncology, Genetic Disorders, and Others), By End User (Hospitals & Clinics, Pharmaceutical & Biotech

  The global telehealth market is expected to grow astonishingly in the near future on account of the rising preference for e-visits. They provide easy access to the required doctors, lower outpatient department (OPD) waiting times, and are cost-effective.   Fortune Business Insights™   published this information in a new report, titled, “ Telehealth Market  Size, Share & COVID-19 Impact Analysis, By Type (Products and Services), By Application (Telemedicine, Patient Monitoring, Continuous Medical Education, and Others), By Modality (Real-time (Synchronous), Store-and-forward (Asynchronous), and Remote Patient Monitoring), By End User (Hospital Facilities, Homecare, and Others), and Regional Forecast, 2020-2027 .” The report further mentions that this market size was   USD 61.40 billion   in 2019 and is projected to reach   USD 559.52 billion   by 2027, exhibiting a CAGR of 25.2% during the forecast period. Request a Sample Copy of Market Research Report :  https://www.fortunebusin